breakthrough cancer pain
Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain
... Objective: Assessment of analgesic effectiveness, safety, and tolerability of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTcP) in routine clinical practice. ...
15
Breakthrough cancer pain – still a challenge
... for breakthrough cancer pain (BCP) has undergone undeniable modification in recent ...of breakthrough pain and afford improved efficacy and a better toxicity profile (limiting ...most ...
8
Single-dose fentanyl sublingual spray for breakthrough cancer pain
... Abstract: Breakthrough cancer pain (BTCP) is defined as a transient exacerbation of pain that arises in patients with otherwise controlled persistent ...significant pain relief is ...
11
<p>Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer</p>
... and breakthrough cancer pain, treatments for cancer and pain (including FPNS), and patients ’ quality of life were described using standard descriptive ...on pain management ...
10
A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
... in breakthrough cancer pain is 100 μ ...new breakthrough pain episode. If more than 4 breakthrough cancer pain episodes occur per day, a dose readjustment of the ...
8
Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm
... BAT: Breakthrough pain assessment tool; BTcP: Breakthrough Cancer Pain; C: Cognitive Function; CAGE: Cut down, annoyed, guilty and eye-opener questionnaire; DN4: Doleur neuropathique-4 ...
8
Assessment and treatment of breakthrough cancer pain: from theory to clinical practice
... Abstract: Breakthrough cancer pain (BTcP) is a common condition in oncological patients. However, its management is still suboptimal. Improved knowledge of BTcP and its manage- ment in clinical ...
9
<p>Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain</p>
... with cancer pain and BTcP associated with meta- static disease, treatment guidelines for cancer pain and BTcP associated with metastatic disease, patient informa- tion fact sheets about ...
11
Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain
... Methods: A 4-year budget impact model was developed for the period 2012–2015 for patients with BTcP from the perspective of the Spanish National Health System. BTcP products included in this model were rapid-onset ...
9
Intranasal fentanyl for pain control: current status with a focus on patient considerations
... with cancer pain were screened for breakthrough cancer pain and, if eligible, received a test dose of fentanyl 50 µ ...whose pain was opioid responsive were entered into the ...
8
Rapid acting fentanyl formulations in breakthrough pain in cancer: drug selection by means of the System of Objectified Judgement Analysis
... per breakthrough event is one or two for each ...with breakthrough cancer pain and considered ease of use and patient preference as part of its ...
19
LONG-TERM SAFETY AND TOLERABILITY OF FENTANYL CITRATE NASAL SPRAY IN THE TREATMENT OF BREAK THROUGH CANCER PAIN (BTCP) IN SUBJECTS TAKING REGULAR OPIOID THERAPY
... in cancer patients experiencing breakthrough cancer ...through Cancer Pain (BTCP) episodes received the fentanyl citrate nasal ...spray. Pain relief score, pain intensity ...
6
An observational feasibility study to assess the safety and effectiveness of intranasal fentanyl for radiofrequency ablations of the lumbar facet joints
... to breakthrough cancer pain, other trials have examined the effectiveness of intranasal fentanyl for other procedures inducing acute ...for pain during third-molar extraction, patients ...
6
Management of breakthrough pain in children with cancer
... release breakthrough pain medication (the same holds true for both ...with cancer using a continuous infusion of one opioid (typically morphine, fentanyl, or hydromorphone; or in the UK, diamorphine) ...
7
Role of intranasal fentanyl in breakthrough pain management in cancer patients
... Abstract: Fentanyl is a strong opioid analgesic, which is commonly used in the form of a transdermal patch for the treatment of chronic cancer pain. An intranasal route of fentanyl administration is a novel ...
8
Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology
... ambulatory cancer patients with breakthrough pain (Payne et al ...of breakthrough pain, and had achieved relief of their breakthrough pain with an ...of ...
6
Download Download PDF
... good pain control, regardless of the occurrence of bone ...of pain are ...of breakthrough pain would have such a pharmacokinetic profi le that it would overlap the episodes of ...
7
Osimertinib making a breakthrough in lung cancer targeted therapy
... However, acquired resistance to EGFR TKIs is mostly driven by a second-site EGFR T790M mutation, which negates their inhibitory activity. Osimertinib (AZD9291, Tagrisso™), an oral, third-generation EGFR TKI, has been ...
5
Nanotechnology-Based Strategies for Early Cancer Diagnosis Using Circulating Tumor Cells as a Liquid Biopsy
... breast cancer patients, and showed that the primary tumor was HER2-negative and 9 patients had HER2 gene amplification in their CTCs ...as cancer progresses and could reflect the status of the recurrent ...
21
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2
... National Cancer Institute or any of the collaborating centres in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products or orga- nizations imply endorsement by the ...
21